Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.65 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | BID | P55957 | 3/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.49 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.49 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.49 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.49 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | EP300 | Q09472 | 1/20 | 0.49 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.49 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.49 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.49 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.49 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 2/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 4/20 | 0.46 |
| ▸ | CTSG | P08311 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574313 | 0.98 | ALOX5 (0.63) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL8398437 | 0.98 | ALOX5 (0.63) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL11164405 | 0.94 | ALOX5 (0.57) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL16788658 | 0.86 | ALOX5 (0.47) | ALOX5PTGS2EGFRERBB2ELANE | |
| SCHEMBL2355153 | 0.86 | ALOX5 (0.70) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL27489482 | 0.85 | ALOX5 (0.50) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL199708 | 0.84 | ALOX5 (0.68) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL10926251 | 0.84 | ALOX5 (0.68) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL11618297 | 0.84 | ALOX5 (0.68) | ALOX5PTGS2TYRBIDMCL1 | |
| SCHEMBL4962037 | 0.84 | ALOX5 (0.68) | ALOX5PTGS2TYRBIDMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3662996-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | Verbio Vereinigte BioEnergie AG (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2019-07-09 | — | — | US | disclosed |
| US-9919299-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2018-03-20 | — | — | US | disclosed |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2016-02-04 | — | — | US | disclosed |
| EP-2969204-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XiMo AG (CH) | 2016-01-20 | — | — | EP | disclosed |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2014-10-16 | — | — | US | disclosed |
| WO-2014139679-A2 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | MSMO1, SQLE, MOGAT2 | ALOX5 220/4885PTGS2 1154/4885TYR 599/4885 |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, PYM1, SQLE | ALOX5 1179/4885PTGS2 3276/4885TYR 383/4885 |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, SQLE, PYM1 | ALOX5 1057/4885PTGS2 3145/4885TYR 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.